These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Localization of a defect in phagocytic function in sarcoidosis]. Belokrinitskiĭ DV; Kudriavitskiĭ AI; Kornev BM; Rumiantseva EG; Shatalov NN Probl Tuberk; 1988; (11):54-8. PubMed ID: 3222239 [No Abstract] [Full Text] [Related]
23. [Use of hemosorption in forms of sarcoidosis highly resistant to drug treatment]. Solodkovskiĭ ML Vrach Delo; 1986 Oct; (10):40-2. PubMed ID: 3798887 [No Abstract] [Full Text] [Related]
25. [T-lymphocyte subsets of bronchoalveolar lavage fluid (BALF) in pulmonary sarcoidosis--correlation with clinical stage]. Hashimoto K Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Mar; 24(3):218-29. PubMed ID: 3488462 [No Abstract] [Full Text] [Related]
26. [Immunologic reactivity of the body in sarcoidosis patients]. Chernushenko EF; Goncharova SI; Kogosova LS Klin Med (Mosk); 1983 Dec; 61(12):44-9. PubMed ID: 6608033 [No Abstract] [Full Text] [Related]
27. [Epithelioid cell granuloma formation and negative conversion of the tuberculin skin test in sarcoidosis]. Nagai S Kekkaku; 1983 Oct; 58(10):552-5. PubMed ID: 6663956 [No Abstract] [Full Text] [Related]
29. Update on immunology of sarcoidosis. Report from the Baltimore Conference. Ossi E; Rossi GA; Semenzato G Sarcoidosis; 1985 Mar; 2(1):16-9. PubMed ID: 2882574 [No Abstract] [Full Text] [Related]
30. Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis. Hance AJ; Douches S; Winchester RJ; Ferrans VJ; Crystal RG J Immunol; 1985 Jan; 134(1):284-92. PubMed ID: 3964815 [TBL] [Abstract][Full Text] [Related]
31. [Macrophage function in sarcoidosis. I. Suppressed oxidative metabolism of macrophages in sarcoidosis in correlation with inflammation]. Müller-Quernheim J; Rubin R; Leimer L; Ferlinz R Prax Klin Pneumol; 1983 Oct; 37(10):1130-3. PubMed ID: 6647236 [No Abstract] [Full Text] [Related]
33. Isolation and characterization of an immunosuppressive protein in serum of patients with sarcoidosis. Göring HD; Lukowsky A; Schubert H; Schwalm I; Leib I Dermatol Monatsschr; 1984; 170(2):96-101. PubMed ID: 6724068 [No Abstract] [Full Text] [Related]
34. Clinical and biochemical aspects of sarcoidosis. With special reference to angiotensin-converting enzyme (ACE). Rømer FK Acta Med Scand Suppl; 1984; 690():3-96. PubMed ID: 6097101 [TBL] [Abstract][Full Text] [Related]
35. [Immunologic disorders in patients with an active form of pulmonary sarcoidosis]. Wolska-Goszka L Wiad Lek; 1984 May; 37(10):777-81. PubMed ID: 6390975 [No Abstract] [Full Text] [Related]
36. The occurrence of natural antibodies in sarcoidosis. Kallings LO; Löfgren S Acta Med Scand Suppl; 1964; 425():33-7. PubMed ID: 5884513 [No Abstract] [Full Text] [Related]
37. [Suppression of macrophage chemotaxis by sera from patients with pulmonary sarcoidosis]. Okuyama Y; Terai T; Yozawa H; Abe S; Osaki Y; Murao M Nihon Kyobu Shikkan Gakkai Zasshi; 1982 Jun; 20(6):663-8. PubMed ID: 7131986 [No Abstract] [Full Text] [Related]
38. [Comparative study of tuberculin sensitivity in sarcoidosis and tuberculosis patients]. Goncharova SI; Chernushenko EF Probl Tuberk; 1983 Jan; (1):39-43. PubMed ID: 6835965 [No Abstract] [Full Text] [Related]